Status:
RECRUITING
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
Lead Sponsor:
University of Michigan Rogel Cancer Center
Conditions:
Breast Carcinoma
Eligibility:
All Genders
Phase:
NA
Brief Summary
This clinical trial studies how well a chemotherapy-induced peripheral neuropathy (CIPN) decision aid works in improving chemotherapy decision making among patients with breast cancer. CIPN involves n...
Eligibility Criteria
Inclusion
- Patients with breast cancer
- Currently receiving cycle three of taxane treatment
- Approval of medical oncologist to enroll patient
- Experiencing any CIPN based on enrollment screening question, "In the last 7 days, what was the severity of your numbness or tingling in your hands or feet at its worst? None, Mild, Moderate, Severe, Very Severe. Patient is eligible if their answer is anything except "None"
- Access to a smartphone or similar device that can complete CIPN DecisionAid via Qualtrics while in the waiting room
Exclusion
- Inability to read or speak English
Key Trial Info
Start Date :
November 13 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06915168
Start Date
November 13 2024
End Date
January 31 2026
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States, 48109